Strongbridge Biopharma PLC Debt to Equity Ratio 2016-2021 | SBBP
Current and historical debt to equity ratio values for Strongbridge Biopharma PLC (SBBP) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strongbridge Biopharma PLC debt/equity for the three months ending June 30, 2021 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2021-06-30 |
$0.05B |
$0.04B |
1.18 |
2021-03-31 |
$0.05B |
$0.06B |
0.94 |
2020-12-31 |
$0.06B |
$0.07B |
0.85 |
2020-09-30 |
$0.04B |
$0.08B |
0.58 |
2020-06-30 |
$0.05B |
$0.05B |
1.04 |
2020-03-31 |
$0.04B |
$0.06B |
0.65 |
2019-12-31 |
$0.05B |
$0.07B |
0.63 |
2019-09-30 |
$0.04B |
$0.08B |
0.54 |
2019-06-30 |
$0.04B |
$0.09B |
0.48 |
2019-03-31 |
$0.06B |
$0.10B |
0.58 |
2018-12-31 |
$0.06B |
$0.11B |
0.51 |
2018-09-30 |
$0.15B |
$-0.01B |
-23.51 |
2018-06-30 |
$0.15B |
$0.01B |
16.63 |
2018-03-31 |
$0.16B |
$0.00B |
87.25 |
2017-12-31 |
$0.12B |
$-0.01B |
-9.72 |
2017-09-30 |
$0.11B |
$-0.02B |
-5.69 |
2017-06-30 |
$0.09B |
$0.01B |
9.55 |
2017-03-31 |
$0.08B |
$0.04B |
2.05 |
2016-12-31 |
$0.07B |
$0.07B |
1.05 |
2016-09-30 |
$0.00B |
$0.06B |
0.07 |
2016-06-30 |
$0.01B |
$0.07B |
0.07 |
2016-03-31 |
$0.01B |
$0.08B |
0.09 |
2015-12-31 |
$0.01B |
$0.09B |
0.07 |
2015-09-30 |
$0.00B |
|
0.00 |
2015-06-30 |
$0.00B |
|
0.00 |
2015-03-31 |
$0.00B |
|
0.00 |